MedCityNews reports that Amazon is teaming up with brand consultancy business Arcadia Group “to launch a brand of consumer-use medical devices for diabetes and hypertension management … Called Choice, the new brand will initially include blood glucose monitors and blood pressure monitors accompanied by supporting mobile apps that offer measurement tracking, data mobility and reminders.”
The story notes that Amazon “has busy in healthcare as of late.” Not only has it acquired PillPack, which offers per-sorted medications, but “there’s also the Amazon-J.P. Morgan-Berkshire Hathaway collaboration. First announced in January, the Boston-based venture will initially focus on tech solutions that will help the three companies’ U.S. employees and their families with healthcare.”
The story notes that Amazon “has busy in healthcare as of late.” Not only has it acquired PillPack, which offers per-sorted medications, but “there’s also the Amazon-J.P. Morgan-Berkshire Hathaway collaboration. First announced in January, the Boston-based venture will initially focus on tech solutions that will help the three companies’ U.S. employees and their families with healthcare.”
- KC's View:
-
Of course they want to connect medical devices to mobile apps, which will then be connected to Amazon’s e-commerce site, which will provide medications and services that will keep consumers inside the company’s ecosystem.
